loading
前日終値:
$49.09
開ける:
$49.08
24時間の取引高:
216.68K
Relative Volume:
0.51
時価総額:
$2.43B
収益:
$379.25M
当期純損益:
$-77.34M
株価収益率:
-31.20
EPS:
-1.6122
ネットキャッシュフロー:
$-27.87M
1週間 パフォーマンス:
-0.51%
1か月 パフォーマンス:
+11.06%
6か月 パフォーマンス:
+17.52%
1年 パフォーマンス:
+48.47%
1日の値動き範囲:
Value
$49.01
$50.41
1週間の範囲:
Value
$47.89
$51.93
52週間の値動き範囲:
Value
$33.64
$54.23

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Name
名前
Mirum Pharmaceuticals Inc
Name
セクター
Healthcare (1160)
Name
電話
650-667-4085
Name
住所
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Name
職員
334
Name
Twitter
@mirumpharma
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
MIRM's Discussions on Twitter

MIRM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MIRM
Mirum Pharmaceuticals Inc
50.30 2.43B 379.25M -77.34M -27.87M -1.6122
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-19 再開されました H.C. Wainwright Buy
2024-04-17 開始されました Stifel Buy
2023-12-18 繰り返されました H.C. Wainwright Buy
2023-11-20 再開されました JP Morgan Overweight
2023-11-13 開始されました Morgan Stanley Overweight
2023-10-24 開始されました Cantor Fitzgerald Overweight
2023-10-17 再開されました Evercore ISI Outperform
2023-09-20 開始されました JMP Securities Mkt Outperform
2022-09-01 開始されました Citigroup Buy
2021-09-20 開始されました JP Morgan Overweight
2020-08-07 アップグレード Raymond James Outperform → Strong Buy
2020-08-03 開始されました H.C. Wainwright Buy
2020-07-31 開始されました Piper Sandler Overweight
2020-06-25 開始されました Robert W. Baird Outperform
2019-08-12 開始されました Citigroup Buy
2019-08-12 開始されました Evercore ISI Outperform
2019-08-12 開始されました Guggenheim Buy
2019-08-12 開始されました ROTH Capital Buy
2019-08-12 開始されました Raymond James Outperform
すべてを表示

Mirum Pharmaceuticals Inc (MIRM) 最新ニュース

pulisher
Jun 17, 2025

Rhumbline Advisers Purchases 2,321 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

Jun 17, 2025
pulisher
Jun 15, 2025

Where are the Opportunities in (MIRM) - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 14, 2025

Insider Sell: William Fairey Sells Shares of Mirum Pharmaceutica - GuruFocus

Jun 14, 2025
pulisher
Jun 12, 2025

High Growth Tech Stocks In The US Market - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Predicts MIRM FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Mirum Pharmaceuticals Expands Team with 10 New Hires, Grants $5.7M Stock Options Package - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo

Jun 10, 2025
pulisher
Jun 08, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Why Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 06, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.06 Million Stock Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharm - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharmaceuticals Inc (MIRM) - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

(MIRM) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 03, 2025
pulisher
May 31, 2025

Mirum pharmaceuticals raises 2025 revenue guidance to $435M-$450M driven by robust growth - MSN

May 31, 2025
pulisher
May 30, 2025

Mirum Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

Alagille Syndrome Treatment Market Detailed in New Research ReportMirum Pharmaceuticals, Albireo Pharma - openPR.com

May 30, 2025
pulisher
May 29, 2025

Two Sigma Investments LP Has $5.23 Million Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

May 29, 2025
pulisher
May 28, 2025

Man Group plc Invests $289,000 in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 28, 2025
pulisher
May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential By Investing.com - Investing.com South Africa

May 26, 2025
pulisher
May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential - Investing.com Nigeria

May 26, 2025
pulisher
May 26, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 26, 2025
pulisher
May 23, 2025

When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

Mirum Pharmaceuticals (MIRM) – Research Analysts’ Weekly Ratings Changes - Defense World

May 22, 2025
pulisher
May 22, 2025

What is HC Wainwright’s Estimate for MIRM Q2 Earnings? - Defense World

May 22, 2025
pulisher
May 21, 2025

Mirum Pharmaceuticals at RBC Conference: Strategic Growth Highlights - Investing.com

May 21, 2025
pulisher
May 20, 2025

Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - citybiz

May 20, 2025
pulisher
May 20, 2025

Comerica Bank Reduces Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 20, 2025
pulisher
May 20, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals Names Doug Sheehy New Chief Legal Officer - Bloomberg Law News

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwri - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Appoints New Chief Legal Officer | - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwright & Co. | MIRM Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating with Promising Growth Potential | MIRM Stock News - GuruFocus

May 19, 2025
pulisher
May 17, 2025

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $60.64 - Defense World

May 17, 2025
pulisher
May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025
pulisher
May 15, 2025

Northern Trust Corp Acquires 32,059 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 15, 2025
pulisher
May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by The Manufacturers Life Insurance Company - Defense World

May 15, 2025
pulisher
May 14, 2025

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

May 14, 2025
pulisher
May 13, 2025

Mirum Pharmaceuticals (MIRM) Maintains Strong Buy Rating with Ra - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Mirum Pharmaceuticals (MIRM) Gets Price Target Boost to $77 | MI - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Trend Tracker for (MIRM) - news.stocktradersdaily.com

May 13, 2025
pulisher
May 12, 2025

FY2025 EPS Estimates for MIRM Raised by Cantor Fitzgerald - Defense World

May 12, 2025
pulisher
May 12, 2025

Leerink Partnrs Brokers Increase Earnings Estimates for MIRM - Defense World

May 12, 2025
pulisher
May 11, 2025

JMP Securities Increases Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $76.00 - Defense World

May 11, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Price Target Raised Following Stron - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Beyond The Numbers: 4 Analysts Discuss Mirum Pharmaceuticals Stock - Benzinga

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Maintains Market Outperform Rating with Higher Price Target | MIRM Stock News - GuruFocus

May 09, 2025

Mirum Pharmaceuticals Inc (MIRM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Mirum Pharmaceuticals Inc (MIRM) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Howe Jolanda
SVP, GLOBAL CONTROLLER
Jul 03 '25
Sale
49.08
477
23,411
2,426
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):